Related Experiment Video
Updated: May 31, 2026

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro
Published on: October 13, 2023
Intravenous immunoglobulin therapy in proximal diabetic neuropathy
Yuichi Kawagashira1, Hirohisa Watanabe, Yumiko Oki
1Nagoya University Graduate School of Medicine, Nagoya, Nagoya, 466-8550, Japan.
Abstract:
A 57-year-old man with type 2 diabetes mellitus for 10 years showed progressive loss of muscle strength in both legs, pain and muscle atrophy in the femoral region and significant weight loss. On admission, he could not stand alone and used a wheelchair. He also complained of severe pain in the lower extremities. He was diagnosed with proximal diabetic neuropathy (PDN) by characteristic clinical and electrophysiological features. Intravenous immunoglobulin therapy (IVIg 0.4 g/kg×5 days) markedly reduced the severe pain and muscle weakness in the legs. Eventually, pain assessed by the Visual Analogue Scale was relieved by 80% and muscle strength was also well recovered, thereby enabling the patient to walk with a cane. The present case suggests that IVIg therapy may be effective for the relief of pain in PDN.
Related Concept Videos
Diabetic Neuropathy
Diabetic Nephropathy
Diabetic Retinopathy
Type I Diabetes II: Pathophysiology
Diabetic Foot Ulcer
Type I Diabetes III: Clinical Manifestations
